• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5): A Comprehensive Overview

Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) is a significant compound in the field of organic chemistry and pharmaceutical research. This molecule, characterized by its cyclobutane ring substituted with a carboxylic acid group, a dimethyl group at the 2-position, and a ketone group at the 3-position, has garnered considerable attention due to its unique structural properties and potential applications in drug development.

The chemical structure of Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) imparts distinct reactivity and functionality. The cyclobutane ring itself is a strained three-membered heterocycle, which can influence the molecule's electronic and steric properties. The presence of the carboxylic acid group at one end of the ring and the ketone group at another makes it a versatile intermediate for synthesizing more complex molecules.

In recent years, there has been growing interest in the use of cycloalkane derivatives as pharmacophores in drug design. The rigid structure of the cyclobutane ring can enhance binding affinity to biological targets, making it an attractive scaffold for medicinal chemists. Specifically, Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) has been explored in several research studies for its potential role in developing novel therapeutic agents.

One of the most compelling aspects of this compound is its utility as a building block in organic synthesis. The combination of functional groups—carboxylic acid and ketone—provides multiple points for further chemical modification. This flexibility has allowed researchers to attach various substituents and explore new chemical pathways. For instance, the carboxylic acid group can be used to form esters or amides, while the ketone group can undergo reduction or oxidation reactions.

Recent studies have highlighted the compound's role in developing bioactive molecules. Researchers have utilized Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) as a precursor in synthesizing analogs of natural products with known biological activities. These analogs have shown promise in preclinical studies as potential treatments for various diseases.

The synthesis of Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) typically involves multi-step organic reactions starting from commercially available precursors. One common synthetic route involves the cyclization of appropriate acyclic precursors followed by functional group transformations to introduce the desired substituents. Advances in synthetic methodologies have made it possible to produce this compound with high purity and yield, facilitating its use in further research.

The pharmacological properties of derivatives of Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) have been extensively studied. Researchers have focused on understanding how structural modifications influence biological activity. For example, replacing the carboxylic acid group with other functional groups has been shown to alter binding interactions with target proteins. Similarly, variations in the substitution pattern around the cyclobutane ring can significantly impact potency and selectivity.

In conclusion, Cyclobutanecarboxylic acid, 2,2-dimethyl-3-oxo- (CAS No. 3183-43-5) is a valuable compound with diverse applications in organic synthesis and pharmaceutical research. Its unique structural features make it an excellent scaffold for developing novel bioactive molecules. As research continues to uncover new synthetic strategies and pharmacological insights, this compound is likely to remain a cornerstone in medicinal chemistry.

• 473-68-7(3-acetyl-2,2-dimethylcyclobutane-1-carboxylic acid)
• 738607-10-8(Cyclobutanecarboxylic acid, 1,1'-(5-oxo-1,9-nonanediyl)bis-)
• 90191-49-4(CYCLOBUTANECARBOXYLIC ACID, 3,3-DIMETHYL-2-(3-OXOBUTYL)-, CIS-)
• 55821-60-8(Cyclobutanecarboxylic acid, 3,3-dimethyl-2-(3-oxobutyl)-)
• 28587-41-9(rac-(1R,3S)-3-acetyl-2,2-dimethylcyclobutane-1-carboxylic acid)
• 1795306-43-2(1-(2-Oxopropyl)cyclobutane-1-carboxylic acid)
• 2138223-58-0(Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl-3-oxo-)
• 22571-79-5(Cyclobutanecarboxylic acid, 3-acetyl-2,2-dimethyl-, (1R,3R)-rel-)
• 2306277-97-2(3-oxospiro[3.3]heptane-1-carboxylic acid)
• 279240-50-5(Cyclobutanecarboxylic acid, 3-acetyl-2,2-dimethyl-, (1s,3s)-(9ci))